Brief: Kinnate Biopharma Q2 Basic EPS USD -0.68
08/08/2023 21:05
Aug 08 (Reuters) - Kinnate Biopharma Q2 operating expenses USD 34.135 million. * Q2 operating income USD -34.135 million * Q2 net income USD -31.918 million
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview